Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial

Barbara M Fischer, Jann Mortensen, Hanne Hansen, Peter Vilmann, Søren Schytt Larsen, Annika Loft Jakobsen, Anne Kiil Berthelsen, Jesper Ravn, Paul Clementsen, Asbjørn Høegholm, Klaus Richter Larsen, Asger Dirksen, Birgit G Skov, Mark Krasnik, Liselotte Højgaard, Ulrik Lassen

67 Citationer (Scopus)

Abstract

Correct mediastinal staging is a cornerstone in the treatment of patients with non-small cell lung cancer. A large range of methods is available for this purpose, making the process of adequate staging complex. The objective of this study was to describe faults and benefits of positron emission tomography (PET)-CT in multimodality mediastinal staging.
OriginalsprogEngelsk
TidsskriftThorax
Vol/bind66
Udgave nummer4
Sider (fra-til)294-300
Antal sider7
ISSN0040-6376
DOI
StatusUdgivet - 1 apr. 2011

Fingeraftryk

Dyk ned i forskningsemnerne om 'Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial'. Sammen danner de et unikt fingeraftryk.

Citationsformater